Walker MD, Silverberg SJ (2018) Primary hyperparathyroidism. Nat Rev Endocrinol 14:115–125. https://doi.org/10.1038/nrendo.2017.104

Article  CAS  PubMed  Google Scholar 

Minisola S, Gianotti L, Bhadada S, Silverberg SJ (2018) Classical complications of primary hyperparathyroidism. Best Pract Res Clin Endocrinol Metab 32:791–803. https://doi.org/10.1016/j.beem.2018.09.001

Article  PubMed  Google Scholar 

Castellano E, Attanasio R, Boriano A, Pellegrino M, Borretta G (2022) Serum phosphate: a neglected test in the clinical management of primary hyperparathyroidism. J Clin Endocrinol Metab 107:e612–e618. https://doi.org/10.1210/clinem/dgab676

Article  PubMed  Google Scholar 

Clarke BL (2022) Is moderate hypophosphatemia a new indication for surgery in asymptomatic primary hyperparathyroidism? J Clin Endocrinol Metab 107:e1756–e1757. https://doi.org/10.1210/clinem/dgab768

Article  PubMed  Google Scholar 

Düğer H, Bostan H, Gül Ü, Uçan B, Hepşen S, Sakız D, Akhanlı P, Çakal E, Kızılgül M (2023) The importance of hypophosphatemia in the clinical management of primary hyperparathyroidism. J Endocrinol Investig. https://doi.org/10.1007/s40618-023-02064-w

Article  Google Scholar 

Weber T, Dotzenrath C, Dralle H et al (2021) Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK). Langenbecks Arch Surg 406:571–585. https://doi.org/10.1007/s00423-021-02173-1

Article  CAS  PubMed  Google Scholar 

Bilezikian JP, Khan AA, Silverberg SJ, Fuleihan GE, Marcocci C, Minisola S, Perrier N, Sitges-Serra A, Thakker RV, Guyatt G, Mannstadt M, Potts JT, Clarke BL, Brandi ML, International Workshop on Primary Hyperparathyroidism (2022) Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop. J Bone Miner Res 37(11):2293–2314. https://doi.org/10.1002/jbmr.4677

Article  PubMed  Google Scholar 

Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, Thakker R, D’Amour P, Paul T, Van Uum S, Shrayyef MZ, Goltzman D, Kaiser S, Cusano NE, Bouillon R, Mosekilde L, Kung AW, Rao SD, Bhadada SK, Clarke BL, Liu J, Duh Q, Lewiecki EM, Bandeira F, Eastell R, Marcocci C, Silverberg SJ, Udelsman R, Davison KS, Potts JT Jr, Brandi ML, Bilezikian JP (2017) Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int 28:1–19. https://doi.org/10.1007/s00198-016-3716-2

Article  CAS  PubMed  Google Scholar 

Madeo B, De Vincentis S, Kara E, Vescini F, Trenti T, Guaraldi G, Rochira V (2019) Reliability of calcium-phosphorus (Ca/P) ratio as a new, accurate and inexpensive tool in the diagnosis of some Ca-P disorders. J Endocrinol Investig 42:1041–1049. https://doi.org/10.1007/s40618-019-01025-6

Article  CAS  Google Scholar 

Madeo B, De Vincentis S, Repaci A, Altieri P, Vicennati V, Kara E, Vescini F, Amadori P, Balestrieri A, Pagotto U, Simoni M, Rochira V (2020) The calcium-to-phosphorous (Ca/P) ratio in the diagnosis of primary hyperparathyroidism and hypoparathyroidism: a multicentric study. Endocrine 68(3):679–687. https://doi.org/10.1007/s12020-020-02276-7

Article  CAS  PubMed  Google Scholar 

Marcocci C, Brandi ML, Scillitani A, Corbetta S, Faggiano A, Gianotti L, Migliaccio S, Minisola S (2015) Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J Endocrinol Investig 38:577–593. https://doi.org/10.1007/s40618-015-0261-3

Article  CAS  Google Scholar 

National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–S266

Google Scholar 

Bertoldo F, Cianferotti L, Di Monaco M, Falchetti A, Fassio A, Gatti D, Gennari L, Giannini S, Girasole G, Gonnelli S, Malavolta N, Minisola S, Pedrazzoni M, Rendina D, Rossini M, Chiodini I (2022) Definition, assessment, and management of vitamin D inadequacy: suggestions, recommendations, and warnings from the Italian Society for Osteoporosis, mineral metabolism and bone diseases (SIOMMMS). Nutrients 14(19):4148. https://doi.org/10.3390/nu14194148

Article  CAS  PubMed  PubMed Central  Google Scholar 

Madeo B, Kara E, Cioni K, Vezzani S, Trenti T, Santi D, Simoni M, Rochira V (2017) Serum calcium to phosphorous (Ca/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism. JBMR Plus 2:109–117. https://doi.org/10.1002/jbm4.10019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anastasilakis DA, Makras P, Polyzos SA, Anastasilakis AD, Part of the COMBO ENDO TEAM 2017 (2019) Asymptomatic and normocalcemic hyperparathyroidism, the silent attack: a combo-endocrinology overview. Hormones (Athens) 18:65–70. https://doi.org/10.1007/s42000-018-0069-6

Article  PubMed  Google Scholar 

Viccica G, Cetani F, Vignali E, Miccoli M, Marcocci C (2017) Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism. Endocrine 55:256–265. https://doi.org/10.1007/s12020-016-0931-8

Article  CAS  PubMed  Google Scholar 

Rao DS, Honasoge M, Divine GW, Phillips ER, Lee MW, Ansari MR, Talpos GB, Parfitt AM (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. J Clin Endocrinol Metab 85:1054–1058. https://doi.org/10.1210/jcem.85.3.6440

Article  CAS  PubMed  Google Scholar 

Sykała M, Szumowski P, Mojsak M, Abdelrazek S, Żukowski Ł, Lipińska D, Juchnicka I, Kozłowska G, Szelachowska M, Krętowski A, Myśliwiec J (2021) Assessment of clinical utility of assaying FGF-23, klotho protein, osteocalcin, NTX, and sclerostin in patients with primary hyperparathyroidism. J Clin Med 13(10):3089. https://doi.org/10.3390/jcm10143089

Article  CAS  Google Scholar 

Castellano E, Attanasio R, Boriano A, Pellegrino M, Garino F, Gianotti L, Borretta G (2017) Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J Clin Endocrinol Metab 102:4148–4152. https://doi.org/10.1210/jc.2017-01080

Article  PubMed  Google Scholar 

Cheng Z, Liang N, Chen TH, Li A, Santa Maria C, You M, Ho H, Song F, Bikle D, Tu C, Shoback D, Chang W (2013) Sex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice. J Bone Miner Res 28:1087–1100. https://doi.org/10.1002/jbmr.1846

Article  CAS  PubMed  Google Scholar 

Zhang D, Maalouf NM, Adams-Huet B, Moe OW, Sakhaee K (2014) Effects of sex and postmenopausal estrogen use on serum phosphorus levels: a cross-sectional study of the National Health and Nutrition Examination Survey (NHANES) 2003–2006. Am J Kidney Dis 63:198–205. https://doi.org/10.1053/j.ajkd.2013.07.012

Article  CAS  PubMed  Google Scholar 

Aggarwal KP, Narula S, Kakkar M, Tandon C (2013) Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed Res Int. https://doi.org/10.1155/2013/292953

Article  PubMed  PubMed Central  Google Scholar 

Saponaro F, Marcocci C, Apicella M, Mazoni L, Borsari S, Pardi E, Di Giulio M, Carlucci F, Scalese M, Bilezikian JP, Cetani F (2020) Hypomagnesuria is associated with nephrolithiasis in patients with asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 105(8):dgaa233. https://doi.org/10.1210/clinem/dgaa233

Article  PubMed  Google Scholar 

Suki WN, Moore LW (2016) Phosphorus regulation in chronic kidney disease. Methodist Debakey Cardiovasc J 12:6–9. https://doi.org/10.14797/mdcj-12-4s1-6

Article  PubMed  PubMed Central  Google Scholar